Paysign, Inc. (PAYS) earnings date
Mar 23, 2027, after close estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 67% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 41 days, typically, give or take 21 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Mon, Nov 9, 2026 | after close | 40 | 8-K |
| Q2 FY2026 | Wed, Aug 5, 2026 | after close | 36 | 8-K |
| Q1 FY2026 | Tue, May 12, 2026 | after close | 42 | 8-K |
| Q4 FY2025 | Tue, Mar 24, 2026 | after close | 83 | 8-K |
| Q3 FY2025 | Wed, Nov 12, 2025 | after close | 43 | 8-K |
| Q2 FY2025 | Tue, Aug 5, 2025 | after close | 36 | 8-K |
| Q1 FY2025 | Thu, May 8, 2025 | after close | 38 | 8-K |
| Q4 FY2024 | Tue, Mar 25, 2025 | after close | 84 | 8-K |
What they guided beta
| Q3 FY2026 | "Patient Affordability Growth Drives Revenue and Margin Expansion Raises Full Year 2026 Gross Margin, Net Income, GAAP EPS and Adjusted EBITDA Guidance Balance Sheet Supports Continued Investment and Growth Initiatives" exhibit |
| Q3 FY2026 | "outlook of $114.0 million to $117.0 million; raising full-year 2026 guidance for Gross Profit Margin, Net Income, GAAP Diluted EPS," exhibit |
| Q3 FY2026 | "That strength, combined with the visibility into additional program launches, gives us confidence we’ll land within our revenue outlook of $114.0 million to $117.0 million but exceed our prior full-year profitability outlook, even after accounting for the 113 centers that we anticipate transitioning to another provider during the fourth quarter." exhibit |
| Q3 FY2026 | "As we look to 2027, the growth we expect from patient affordability remains on track, and the transition of these centers does not change that trajectory." exhibit |
| Q3 FY2026 | "Paysign expects to exit 2026 with 190-195 active patient affordability programs and 445–450 plasma centers." exhibit |
| Q2 FY2026 | "Paysign Reports Record Second Quarter 2026 Revenue of $28.3 Million, Up 48%; Raises Full-Year Outlook" exhibit |
| Q2 FY2026 | "· Raising full-year 2026 outlook – revenue $114.0 million to $117.0 million; Adjusted EBITDA $35.0 million to $38.0 million" exhibit |
| Q2 FY2026 | "Paysign expects to exit the third quarter of 2026 with 165–170 active patient affordability programs and 561–563 plasma centers." exhibit |
| Q2 FY2026 | "A call replay will be available until November 4, 2026, and can be accessed by dialing 877.660.6853 (within the U.S.) and +1.201.612.7415 (outside the U.S.), using passcode 13761445." exhibit |
| Q2 FY2026 | "Such forward-looking statements include, among others, our belief that strong growth in our patient affordability business, steady performance in plasma donor compensation, and disciplined execution across the company drove meaningful operating leverage and profitability, reinforcing the multiyear strategy we have been building; our belief that with momentum across the business and a robust pipeline of opportunities, we intend to remain focused on sustainable growth, continued margin expansion, and creating long-term value for shareholders; our belief that our patient affordability solutions c" exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/PAYS
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/PAYS
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/PAYS/"><img src="https://veritasdata.dev/embed/PAYS.svg" alt="PAYS earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/PAYS/)
Script
<script async src="https://veritasdata.dev/embed/PAYS.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/PAYS"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.